Amundi
- SEC CIK
- 0001330387
- Latest filing
- Aug 26, 2026
JAZZ holding history
Jazz Pharmaceuticals plc in every 13F filed by Amundi, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
JAZZ overviewAll 13F holders of JAZZFull Q2 2026 holdings
- Shares (Q2 2026)
- 79,323
- Value
- $19.1M
- % of portfolio
- <0.1%
- Quarters held
- 19
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 79,323 | $19.1M | <0.1% | +23,683+42.6% | Added | Holders |
| Q1 2026 | 55,640 | $10.5M | <0.1% | +53,454+2,445.3% | Added | Holders |
| Q4 2025 | 2,186 | $371.6K | <0.1% | +2,186 | New | Holders |
| Q2 2025 | 0 | $0 | 0.0% | −72,068−100.0% | Sold out | Holders |
| Q1 2025 | 72,068 | $8.71M | <0.1% | −8,413−10.5% | Reduced | Holders |
| Q4 2024 | 80,481 | $9.68M | <0.1% | −14,882−15.6% | Reduced | Holders |
| Q3 2024 | 95,363 | $10.3M | <0.1% | +85,832+900.6% | Added | Holders |
| Q2 2024 | 9,531 | $986.7K | <0.1% | −50,731−84.2% | Reduced | Holders |
| Q1 2024 | 60,262 | $6.58M | <0.1% | −13,181−17.9% | Reduced | Holders |
| Q4 2023 | 73,443 | $8.99M | <0.1% | +10,054+15.9% | Added | Holders |
| Q3 2023 | 63,389 | $8.18M | <0.1% | +3,958+6.7% | Added | Holders |
| Q2 2023 | 59,431 | $7.38M | <0.1% | −128,453−68.4% | Reduced | Holders |
| Q1 2023 | 187,884 | $27.4M | <0.1% | +23,980+14.6% | Added | Holders |
| Q4 2022 | 163,904 | $25.4M | <0.1% | +945+0.6% | Added | Holders |
| Q3 2022 | 162,959 | $22.2M | <0.1% | +31,466+23.9% | Added | Holders |
| Q2 2022 | 131,493 | $20.4M | <0.1% | −9,945−7.0% | Reduced | Holders |
| Q1 2022 | 141,438 | $23.9M | <0.1% | +24,989+21.5% | Added | Holders |
| Q4 2021 | 116,449 | $16.7M | <0.1% | −41,350−26.2% | Reduced | Holders |
| Q3 2021 | 157,799 | $20.5M | <0.1% | +147+0.1% | Added | Holders |
| Q2 2021 | 157,652 | $28.0M | <0.1% | – | No prior filing | Holders |